AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,283,520 | +8.3% | 144,000 | 0.0% | 0.26% | -15.0% |
| Q2 2023 | $6,723,360 | +7.2% | 144,000 | -12.2% | 0.31% | -13.8% |
| Q1 2023 | $6,274,640 | -30.2% | 164,000 | 0.0% | 0.36% | -42.7% |
| Q4 2022 | $8,987,200 | -9.6% | 164,000 | -43.8% | 0.62% | -36.1% |
| Q3 2022 | $9,943,000 | +262.8% | 292,000 | +0.7% | 0.97% | +238.0% |
| Q2 2022 | $2,741,000 | – | 290,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 103,816 | $5,251,013 | 6.02% |
| Boxer Capital, LLC | 1,676,733 | $84,809,155 | 4.52% |
| Redmile Group, LLC | 1,769,684 | $89,510,617 | 4.26% |
| Ghost Tree Capital, LLC | 250,000 | $12,645,000 | 4.16% |
| Logos Global Management LP | 600,000 | $30,348,000 | 4.05% |
| COMMODORE CAPITAL LP | 565,000 | $28,577,700 | 3.34% |
| Yiheng Capital Management, L.P. | 1,221,674 | $61,792,271 | 3.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $10,116,000 | 3.07% |
| Atlas Venture Life Science Advisors, LLC | 359,251 | $18,170,915 | 2.81% |
| Perceptive Advisors | 1,619,425 | $81,910,517 | 2.73% |